1 Mar 2024
Pharmista accepted into BioInnovation Institute program
Pharmista, already a participant in the SmiLe life sciences start-up business incubator program has now been accepted to the BioInnovation Institute (BII) Venture Lab program in Copenhagen.
19 Oct 2023
Patent breakthrough for reusable pregnancy test device
Pharmista Technologies, has announced that the European Patent Organisation (EPO) has approved their European patent application for "A REUSABLE TEST DEVICE"
7 Feb 2023
RAPIvD strengthens ties with Stream Bio
RAPIvD has signed a partnership agreement with Stream Bio to use their conjugated polymer nanoparticles (CPNs) in lateral flow assay development projects.
9 Dec 2022
RAPIvD Achieves ISO 13485 Certification
RAPIvD has achieved certification for
meeting ISO 13485 medical devices standards for ‘contract development and manufacture of lateral
flow assays for IVD’